… may be useful in early diagnosis and staging of thyroid tumors. The aim of … of p53 and sFasL
blood concentration in patients with benign follicular adenoma and follicular thyroid cancer. …

… to evaluate p53 and sFasL plasma concentration in patients … Fas ligand (CD95L) binds to
its receptor Fas, thus activating … follicular neoplasm and all patients with malignant cancers (…

… of p53 protein and soluble FasL ligand level concentration in … sFasL and p53 concentrations
in blood serum of patients with … Plasma soluble fas and soluble fas ligand in chronic …

… that sFasL may be useful marker in the assessment of thyroid … sFasL levels in children with
HT support active apoptosis of … serum sFasL may serve as an indicator of apoptotic thyroid …

… cardiomyopathy: a short review. Mol Cell Biochem 2004; 261:187-91. 16. … p53 and soluble
Fas ligand (sFasL) serum level concentration as indicators of apoptosis in serum of patients …

… This review will focus on serum apoptotic markers in the … Fas ligand (sFasL) and Cyt c in
circulation during cancer therapy … plasma p53 and sFasL in benign and malignant thyroid …

… serum maker of apoptosis is soluble Fas ligand, which is the … p53 and cytochrome c levels
as markers of apoptosis in the … a proper indicator for demonstration of cardiomyocyte apoptosis …

… We evaluated the relationship between sCD95 levels and … -induced apoptosis, despite the
high concentration of CD95L … higher levels of soluble CD95 in serum of women with cancer …

… There is a need to explore a panel of preventive measures, … evaluated the effect of regular
consumption of Rg3 on serum … , including inducing the apoptosis of tumor cells, promoting T …

… the soluble (sFasL). In order to bind and activate its cognate … to more conveniently apprehend
and evaluate the grade- and … , p53-dependent apoptosis mainly implemented through Fas, …